News › Industry News, State Laws

Massachusetts Health Care Company Pleads Guilty to Purchasing, Using Botox Not Approved for Use in U.S.

April 28, 2023
Syringe and vials

A Massachusetts health care company has pleaded guilty and agreed to pay millions after officials said it purposefully bought and used Botox that was only labeled for sale in foreign countries.

The Waltham-based Greater Boston Behavioral Health must now pay more than $2.5 million in fines and forfeiture.

“Greater Boston Behavioral Health disregarded laws designed to protect patient safety,” U.S. Attorney Rachael Rollins said in a statement. “The U.S. Attorney’s Office is committed to protecting patients and the integrity of federal health care programs, and we will continue to use our criminal authority to ensure that health care providers play by the rules that protect the public and ensure quality of care.”

Read more at Boston.com >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA